Faculty profile
Anil Maharaj
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Population Pharmacokinetics and Exposure-Safety Analysis of Furosemide in Preterm Infants.
Journal of clinical pharmacology · 2026
The Promising Role of Pediatric Pharmacokinetic Simulations in Informing Opioid Dosing Decisions.
Anesthesia and analgesia · 2026
Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single arm clinical trial.
Addiction science & clinical practice · 2025
Latest funding
- $1,273,725
Novel therapeutics for neurodegeneration - Targeting NUDT5 in Alzheimer's Disease
CIHR · 2025 · Co-investigator
- $12,500
Development of an ex-vivo-in-silico framework for predicting maternal and breastfed-infant toxicokinetics
NSERC · 2022 · Principal investigator
- $78,000
Development of an ex-vivo-in-silico framework for predicting maternal and breastfed-infant toxicokinetics
NSERC · 2022 · Principal investigator
8 publications.
Population Pharmacokinetics and Exposure-Safety Analysis of Furosemide in Preterm Infants.
Randell RL, Maharaj A, Laughon M, Hornik CD, Greenberg RG, Lang JE, Cohen-Wolkowiez M, Hornik CP, Anand R, Martz K, Payne EH, Watt K, Muller WJ, Courtney SE, Atz A, Al-Uzri A, Sokol GM, Bloom BT, Iyengar A, Hanna M, Benjamin DK, Balevic SJ, Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee
The Promising Role of Pediatric Pharmacokinetic Simulations in Informing Opioid Dosing Decisions.
Gheshlaghi N, Mufti K, Zhang JH, Scott EN, Maharaj A, Loucks CM
Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single arm clinical trial.
Azar P, Ignaszewski MJ, Harris M, Barazanci Z, Davison R, Wong JSH, Maharaj A, Mathew N, Hall D, Guillemi SA, Foreman J, Barrios R, Montaner JSG
The Relationship of Indomethacin Exposure With Efficacy and Renal Toxicity Outcomes for Preterm Infants in the Neonatal Intensive Care Unit.
Yeung CHT, Sekulich DC, Scott A, Nolte WM, Gibson K, Su R, Alrifai MW, Lopata SM, Lewis T, Reese J, Maharaj A
A Simulation-Based Assessment of Levetiracetam Concentrations Following Fixed and Weight-Based Loading Doses: A Meta-Regression and Pharmacokinetic Modeling Analysis.
Lau A, Haag H, Maharaj A
Pharmacokinetics and Proposed Dosing of Levetiracetam in Children With Obesity.
Zimmerman KO, Wu H, Maharaj A, Turner A, Chen JY, Hornik CD, Arnold S, Muller W, Al-Uzri A, Meyer M, Shiloh-Malawsky Y, Taravath S, Lakhotia A, Joshi C, Jackman J, Hornik CP
Understanding the Impact of Age-Related Changes in Pediatric GI Solubility by Multivariate Data Analysis.
Guimarães M, Maharaj A, Edginton A, Vertzoni M, Fotaki N
Simultaneous SPECT imaging with 123I and 125I - a practical approach to assessing a drug and its carrier at the same time with dual imaging.
Nosrati Z, Esquinas PL, Rodríguez-Rodríguez C, Tran T, Maharaj A, Saatchi K, Häfeli UO
Novel therapeutics for neurodegeneration - Targeting NUDT5 in Alzheimer's Disease
Principal investigators: Page, Brent
Keywords: Alzheimer'S Disease; Drug Discovery; Medicinal Chemistry; Neuroinflammation; Nudix Hydrolase; Nudt5
Development of an ex-vivo-in-silico framework for predicting maternal and breastfed-infant toxicokinetics
Principal investigators: Maharaj, Anil
Development of an ex-vivo-in-silico framework for predicting maternal and breastfed-infant toxicokinetics
Principal investigators: Maharaj, Anil
Keywords: toxicology; toxicokinetics; risk assessment; applied mathematics; computational biology
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Anthony Lau and Pouya Azar: 4 shared papers
- Rolando Barrios and Pouya Azar: 2 shared papers
- Rolando Barrios and Anil Maharaj: 1 shared paper
- Anthony Lau and Anil Maharaj: 1 shared paper
- Andrea Edginton and Anil Maharaj: 1 shared paper
- Anil Maharaj and Pouya Azar: 1 shared paper
- Pharmaceutical Sciences
- School of Pharmacy
- Chemical and Biological Engineering
- Other
Co-authors at University of British Columbia, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.